Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AlloStim +/- Cryoablation in Metastatic Colorectal Cancer
NCT02380443Phase 2Completed
- Sponsor
- Mirror Biologics, Inc.
- Start
- Sep 2016
- Primary completion
- Mar 2018
- Modality
- Native Immune Cells
- Countries
- 1
01
Overview
A Phase 2 trial of allostim in metastatic colorectal cancer (mCRC), sponsored by Mirror Biologics, Inc.. Started Sep 2016; status: completed.
02
Drugs
allostim
03
Conditions
metastatic colorectal cancer (mCRC)
Beyond the preview
Go deeper on NCT02380443.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02380443.